ProQR Therapeutics (PRQR) Assets (2012 - 2026)
ProQR Therapeutics (PRQR) posted Assets of $115.9 million for Q1 2026, down 11.66% sequentially from $131.3 million in Q4 2025, and down 27.34% YoY from $159.6 million in Q1 2025.
ProQR Therapeutics (PRQR) Assets (2012 - 2026) Analysis & Trends
ProQR Therapeutics has reported Assets for 15 years, with the latest figure at $115.9 million in Q1 2026.
- Quarterly Assets fell 27.34% year-over-year to $115.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $115.9 million (down 27.34% YoY) and the FY2025 annual result came in at $131.3 million, down 26.87% from the prior year.
- Assets declined to $115.9 million in Q1 2026 per PRQR's latest filing, from $131.3 million in the prior quarter.
- Over five years, Assets peaked at $213.5 million in Q1 2022 and troughed at $115.9 million in Q1 2026.
- A 5-year average of $153.1 million and a median of $154.6 million in 2023 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2023: Assets plunged 99.81% in 2022, then rose 25.97% in 2023.
- Over 5 years, Assets stood at $174.8 million in 2022, then retreated by 15.12% to $148.4 million in 2023, then advanced by 20.98% to $179.5 million in 2024, then retreated by 26.87% to $131.3 million in 2025, then decreased by 11.66% to $115.9 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $115.9 million, $131.3 million, and $145.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | 115.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 115.94 Mn |
| Dec 31, 2025 | 131.25 Mn |
| Sep 30, 2025 | 145.37 Mn |
| Jun 30, 2025 | 155.69 Mn |
| Mar 31, 2025 | 159.56 Mn |
| Dec 31, 2024 | 179.48 Mn |
| Sep 30, 2024 | 117.35 Mn |
| Jun 30, 2024 | 127.13 Mn |
| Mar 31, 2024 | 134.57 Mn |
| Dec 31, 2023 | 148.35 Mn |
| Sep 30, 2023 | 154.62 Mn |
| Jun 30, 2023 | 161.15 Mn |
| Mar 31, 2023 | 169.60 Mn |
| Dec 31, 2022 | 174.79 Mn |
| Sep 30, 2022 | 122.74 Mn |
| Jun 30, 2022 | 191.06 Mn |
| Mar 31, 2022 | 213.51 Mn |
| Dec 31, 2021 | 239.75 Mn |
| Sep 30, 2021 | 230.35 Mn |
| Jun 30, 2021 | 195.52 Mn |